Importantly, in our most recent study (36), we demonstrated that GFI1 modulates sphingolipid metabolism in MM cells to increase intracellular S1P by acting as a direct repressor of S1P phosphatase 1 (SGPP1) gene transcription in all types of MM cells regardless of their p53 status. Here, GFI1 is linked to Miyoshi myopathy.